FDA Inspection 1114422 — Anaheim Clinical Trials LLC
The FDA completed an inspection of Anaheim Clinical Trials LLC on December 18, 2019 in Anaheim, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 18, 2019
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Anaheim, CA (United States)
Additional Details
Clinical BA/BE